E

Potential of CAR T cell therapy targeting Glioblastoma

Encouraging new developments in GBM with a novel CAR T cell therapy

April 18, 2017
E

Overcoming Cancer Immunotherapy Resistance

How do we overcome resistance to cancer immunotherapies? Here, we have an in-depth interview with a thought leader in this space.

April 17, 2017
E

Dan Chen outlines his vision for the Future of Cancer Immunotherapy at AACR17

Dr Daniel Chen from Roche/Genentech shares his vision for the future of cancer immunotherapy at AACR17.

April 13, 2017
E
AACR17 audience

Five Emerging Cancer Research Trends at AACR17

Five emerging cancer research trends we picked up at AACR17 that you should be aware of.

April 11, 2017
E

What does atezolizumab TNBC data presented at AACR17 tell us about breast cancer immunotherapy?

Interview with Professor Peter Schmid, Barts Cancer Institute.

April 10, 2017
E

Corvus CPI-444 Data Disappoints at AACR 2017

Commentary on Tuesday at 2017 AACR annual meeting in Washington DC.

April 5, 2017
E

A Busy Monday at AACR 2017

Commentary on Monday at the 2017 AACR annual meeting.

April 4, 2017
E

Sunday at AACR 2017 annual meeting

Commentary on Sunday at the 2017 AACR annual meeting

April 3, 2017
E

Reflections on Saturday at AACR17

Highlights from Day 1 at AACR17

April 1, 2017
E

AACR 2017 Preview 10

A look at some of the key sessions featuring checkpoint blockade at the AACR 2017 annual meeting

March 29, 2017
E

AACR 2017 Preview 9

A comprehensive review of the key abstracts in the CAR T cell therapy niche and hints of the latest emerging trends

March 23, 2017
E

AACR 2017 Preview 8

A look at how research into transcription factors, super enhancers, chromatin regulation and broom/chromodomains is changing the way we look at cancer

March 22, 2017
E

AACR 2017 Preview 7

With increasing competition in the CDK4/6 space in HR+ HER2- metastatic breast cancer, how are things shaping up?

March 21, 2017
E

AACR 2017 Preview 6

A look at a new area of immune-oncology that looks set to be in the consciousness more over the next few years

March 15, 2017
E

AACR 2017 Preview 5

PARP! PARP! What's hot in ovarian cancer at SGO and AACR?

March 13, 2017
E

AACR 2017 Preview 4

Overcoming immune suppression in the tumour microenvironment

March 9, 2017
E

AACR 2017 Preview 3

Washington Monument After exploring a mechanistic approach and a tumour type as part of our AACR annual…

March 8, 2017
E

AACR 2017 Preview 2

A look at some recent clinical data and what we can learn from the new data expected at AACR in DC

March 7, 2017
E

AACR 2017 Preview 1

The first of our strategic and thematic AACR Previews for the 2017 annual meeting is here

March 6, 2017